Arbele focuses on the development of novel next-gen CAR T and BiMAb immunotherapies to treat solid cancers. The company is building a highly attractive portfolio of drug candidates to potentially cure major gastrointestinal tumors including liver, stomach, colon, esophageal and pancreatic.
5/F, Biotech Center 2, 11 Science Park West Ave., HKSTP, Shatin, N.T.
Hong Kong +(852)-36203002
USA: +(425) 628-2800